Skip to main navigation Skip to search Skip to main content

High‐ and low‐leukemogenic variants of the radiation leukemia virus (RadLV) differ in ability to induce tumor‐specific immune suppression

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Adult C57BL/6 mice inoculated intrathymically (i.t.) with the highly leukemogenic variant of the radiation leukemia virus (A‐RadLV) develop suppressor cells capable of specifically abrogating a potential anti‐tumor cytotoxic response in vitro. Suppressor cells were generated directly by the virus, independently of an initiation of a leukemogenic process. Inoculation of C57BL/6 animals with the low leukemogenic D‐RadLV variant did not result in suppressor cell generation. It is proposed that induction of tumor‐specific immune suppression by A‐RadLV is essential for tumor progression, and the leukemogenic activity of D‐RadLV is attributed to its inability to recruit suppressor cells.

Original languageEnglish
Pages (from-to)355-359
Number of pages5
JournalInternational Journal of Cancer
Volume30
Issue number3
DOIs
StatePublished - 15 Sep 1982

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'High‐ and low‐leukemogenic variants of the radiation leukemia virus (RadLV) differ in ability to induce tumor‐specific immune suppression'. Together they form a unique fingerprint.

Cite this